Conditional depletion of mast cells has no impact on the severity of experimental epidermolysis bullosa acquisita. - Wikidata - awgldk - TriplyDB

Conditional depletion of mast cells has no impact on the severity of experimental epidermolysis bullosa acquisita.

Conditional depletion of mast cells has no impact on the severity of experimental epidermolysis bullosa acquisita.

http://www.wikidata.org/entity/Q41441615

about

Ablation of a small subpopulation of diabetes-specific bone marrow-derived cells in mice protects against diabetic neuropathy.Epidermolysis Bullosa Acquisita: From Pathophysiology to Novel Therapeutic Options.Signalling and targeted therapy of inflammatory cells in epidermolysis bullosa acquisita.The retinoid-related orphan receptor alpha is essential for the end-stage effector phase of experimental epidermolysis bullosa acquisita.Reduced skin blistering in experimental epidermolysis bullosa acquisita after anti-TNF treatment.Regulatory T Cells Suppress Inflammation and Blistering in Pemphigoid Diseases.CD11b-deficient mice exhibit an increased severity in the late phase of antibody transfer-induced experimental epidermolysis bullosa acquisita.Pathways of immediate hypothermia and leukocyte infiltration in an adjuvant-free mouse model of anaphylaxis.Whole-Genome Expression Profiling in Skin Reveals SYK As a Key Regulator of Inflammation in Experimental Epidermolysis Bullosa Acquisita.The Role of Mast Cells in Autoimmune Bullous Dermatoses.The Autoimmune Skin Disease Bullous Pemphigoid: The Role of Mast Cells in Autoantibody-Induced Tissue Injury.

P2860

Q37148729-60C99257-E49F-4FFF-AFF6-A04625109BC3 Q38695599-C28F2B0C-4B8A-461A-939F-1368CB20637A Q38749755-630CA834-C1BB-4DA6-A792-D5694F70B645 Q40962777-A611775C-A277-49E1-8A4B-E54892EB461A Q42320550-7AD830AB-7229-4ACB-B9F0-6688490F3063 Q46244253-DAE7354A-5B07-45EA-B55D-2C1921CF215F Q48149084-F2E8B3AD-EFC9-40EE-9BCD-DCF295A46726 Q50059828-4B7F31C1-F9CF-4FD2-A639-665C7F7EFAA4 Q50333828-94DA7DEB-E340-44EE-857E-349E0EE4072F Q52655233-19672349-2843-4F37-BCC4-940ECADBB617 Q55104920-898509E5-4F69-48AD-8A54-3DB0D49D8964

P2860

Conditional depletion of mast cells has no impact on the severity of experimental epidermolysis bullosa acquisita.

http://www.wikidata.org/entity/Q41441615

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Conditional depletion of mast ...... idermolysis bullosa acquisita.

@en

type

label

Conditional depletion of mast ...... idermolysis bullosa acquisita.

@en

prefLabel

Conditional depletion of mast ...... idermolysis bullosa acquisita.

@en

P1433

Q41441615-E539C3B0-3C93-4C6D-AAF4-E0BA9B484580

P1476

Q41441615-B33601BF-EDF0-4BD7-B40E-CF6509D827BE

P2093

Q41441615-645086A1-12CD-4610-9FAF-8D3BBB006703

Q41441615-9C94F458-97E2-4584-B715-441FDF6039A1

Q41441615-A1A389CE-792C-45BE-94FE-B09A706E6F7D

Q41441615-A8A52F3F-DDD0-4273-9064-901D1AA2F738

Q41441615-BB90CDEA-81EB-4D71-B0FD-AC9599CD00F4

Q41441615-CDA1DC80-C68B-4E85-9CFF-23AA7137CCA6

P2860

Q41441615-0C24DEEF-5393-4391-BEFA-5EAE2851DAF7

Q41441615-173F927E-D503-4D1E-B6A7-0CFFE2AD2BAD

Q41441615-17C41860-9974-492F-BBF0-A0D6859AA89C

Q41441615-19774554-0D42-4116-A5A0-379B89763941

Q41441615-1CE2537D-287D-4EBF-9A56-46A6B0F79E72

Q41441615-276F81B6-9CF8-4E21-A496-715C67C2CB9D

Q41441615-2A2EEE64-F2DA-4978-8249-A177B21EBE63

Q41441615-3060CC9E-719A-4A57-B4F9-898E4BFBF467

Q41441615-3D707C0D-B0AF-4F3F-B515-5F8626CBBCD1

Q41441615-40ED4E77-0ED9-413E-AAD9-3E7AEDFF79CE

P304

Q41441615-6A665B56-910D-4E2A-A947-B915283E2FE0

P31

Q41441615-EF928C00-1FE0-4424-B8CE-2C8C8D48453D

P356

Q41441615-5BC2BE18-C69A-40C8-A195-9582046967DA

P407

Q41441615-A8687B67-72B9-42B6-8577-7505198C8EF4

P433

Q41441615-D7AC2C93-A2A5-47B3-A772-DE9C55C70268

P478

Q41441615-210A2361-5FDE-4033-8081-10311049BBAF

P50

Q41441615-564E7499-0B03-4ED6-B90E-EC148F0BD191

Q41441615-DAFEBB2C-CAD7-414D-B5F8-CE2436D4CFC3

P577

Q41441615-94B57C61-A3E2-4250-958E-7891299DE42D

P698

Q41441615-BC35571B-042D-4818-831A-7B48E93AA427

P356

P1433

European Journal of Immunology

P1476

Conditional depletion of mast ...... pidermolysis bullosa acquisita

@en

P2093

Anika Kasprick

http://www.w3.org/2001/XMLSchema#string

Detlef Zillikens

http://www.w3.org/2001/XMLSchema#string

Frank Petersen

http://www.w3.org/2001/XMLSchema#string

Hendri H Pas

http://www.w3.org/2001/XMLSchema#string

Julia Scholten

http://www.w3.org/2001/XMLSchema#string

Xinhua Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo

Immunomodulatory mast cells: negative, as well as positive, regulators of immunity

A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.

Mast cells: a cellular link between autoantibodies and inflammatory arthritis.

Mast cells in autoimmune disease.

Kit (W-sh) mice develop earlier and more severe experimental autoimmune encephalomyelitis due to absence of immune suppression.

The Wsh and Ph mutations affect the c-kit expression profile: c-kit misexpression in embryogenesis impairs melanogenesis in Wsh and Ph mutant mice.

Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen.

Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy?

Mast cells as "tunable" effector and immunoregulatory cells: recent advances.

P304

1462-1470

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EJI.201444769

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25678008

http://www.w3.org/2001/XMLSchema#string